干扰素与骨质疏松关系的研究进展

被引:7
作者
周隆
付勤
机构
[1] 中国医科大学附属盛京医院脊柱关节骨科
关键词
干扰素; 骨质疏松; 骨免疫学;
D O I
暂无
中图分类号
R580 [];
学科分类号
摘要
近些年来骨骼系统与免疫系统的相互作用关系引起了人们的兴趣。作为免疫调节因子中的重要成员,干扰素同样对骨形成和骨吸收有着重大影响。目前发现与骨质疏松相关的干扰素主要包括IFN-α、IFN-β以及IFN-γ,本文对干扰素在骨质疏松形成过程中发挥的作用做了详细阐述,以期为骨质疏松症的防治提供新的思路。目前干扰素与骨质疏松关系的相关研究取得了较大的进步,在临床试验中,干扰素对部分继发骨质疏松症患者的治疗效果令人满意,想要把研究结果转化为临床仍是一条较漫长的道路。干扰素的应用仍存在很多问题,这些问题如果得到妥善解决,将有助于将干扰素顺利应用于临床,也必将促使骨质疏松的防治水平进一步提高。
引用
收藏
页码:1397 / 1401
页数:5
相关论文
共 17 条
[1]
The Role of IL-1 β in the Bone Loss during Rheumatic Diseases.[J].Piero Ruscitti;Paola Cipriani;Francesco Carubbi;Vasiliki Liakouli;Francesca Zazzeroni;Paola Di Benedetto;Onorina Berardicurti;Edoardo Alesse;Roberto Giacomelli;Nina Ivanovska.Mediators of Inflammation.2015,
[2]
Interferon (IFN)-γ-mediated inflammation and the kynurenine pathway in relation to bone mineral density: the Hordaland Health Study [J].
Apalset, E. M. ;
Gjesdal, C. G. ;
Ueland, P. M. ;
Midttun, O. ;
Ulvik, A. ;
Eide, G. E. ;
Meyer, K. ;
Tell, G. S. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2014, 176 (03) :452-460
[3]
Interferon-γ Plays a Role in Bone Formation In Vivo and Rescues Osteoporosis in Ovariectomized Mice [J].
Duque, Gustavo ;
Huang, Dao Chao ;
Dion, Natalie ;
Macoritto, Michael ;
Rivas, Daniel ;
Li, Wei ;
Yang, Xian Fang ;
Li, Jiarong ;
Lian, Jing ;
Marino, Faleh Tamim ;
Barralet, Jake ;
Lascau, Viorica ;
Deschenes, Claire ;
Ste-Marie, Louis-Georges ;
Kremer, Richard .
JOURNAL OF BONE AND MINERAL RESEARCH, 2011, 26 (07) :1472-1483
[4]
Interferon Alpha and Pamidronate in Osteoporosis with Fracture Secondary to Mastocytosis [J].
Laroche, Michel ;
Livideanu, Christina ;
Paul, Carle ;
Cantagrel, Alain .
AMERICAN JOURNAL OF MEDICINE, 2011, 124 (08) :776-778
[5]
Nitric oxide and bone.[J].Sunil J.Wimalawansa.Annals of the New York Academy of Sciences.2010, 1
[6]
The effect of interferon beta 1B on bone mineral density in multiple sclerosis patients [J].
Varoglu, Asuman Orhan ;
Varoglu, Erhan ;
Bayraktar, Rezzan ;
Aygul, Recep ;
Ulvi, Hizir ;
Yildirim, Kadir .
JOURNAL OF BACK AND MUSCULOSKELETAL REHABILITATION, 2010, 23 (01) :25-29
[7]
Osteoimmunology: Crosstalk Between the Immune and Bone Systems [J].
Nakashima, Tomoki ;
Takayanagi, Hiroshi .
JOURNAL OF CLINICAL IMMUNOLOGY, 2009, 29 (05) :555-567
[8]
1-Alpha, 25-dihydroxy vitamin D3 inhibits osteoclastogenesis through IFN-beta-dependent NFATc1 suppression [J].
Sakai, Sadaoki ;
Takaishi, Hironari ;
Matsuzaki, Kenichiro ;
Kaneko, Hironori ;
Furukawa, Mitsuru ;
Miyauchi, Yoshiteru ;
Shiraishi, Ayako ;
Saito, Keiji ;
Tanaka, Akio ;
Taniguchi, Tadatsugu ;
Suda, Toshio ;
Miyamoto, Takeshi ;
Toyama, Yoshiaki .
JOURNAL OF BONE AND MINERAL METABOLISM, 2009, 27 (06) :643-652
[9]
Prospective study of bone mineral density and metabolism in patients with chronic hepatitis C during pegylated interferon α and ribavirin therapy [J].
Hofmann, W. P. ;
Kronenberger, B. ;
Bojunga, J. ;
Stamm, B. ;
Herrmann, E. ;
Buecker, A. ;
Mihm, U. ;
von Wagner, M. ;
Zeuzem, S. ;
Sarrazin, C. .
JOURNAL OF VIRAL HEPATITIS, 2008, 15 (11) :790-796
[10]
Favorable effect of immunomodulator therapy on bone mineral density in multiple sclerosis [J].
Shuhaibar, M. ;
McKenna, M. J. ;
Au-Yeong, M. ;
Redmond, J. M. T. .
IRISH JOURNAL OF MEDICAL SCIENCE, 2009, 178 (01) :43-45